SEC Company Response from Nexicon (CIK 0001053113) — Jun 28, 2005
Nexicon (CIK 0001053113)
Date: June 28, 2005 · CIK: 0001053113 · Accession: 0001144204-05-020090
AI Filing Summary & Sentiment
Referenced dates: June 14, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
NEXICON, INC.
400 Gold Avenue, SW, Suite 1000
Albuquerque, New Mexico 87102
(505) 248-0000
June 27, 2005
VIA FEDERAL EXPRESS AND EDGAR
Mr. Larry Spirgel, Assistant Director Division of Corporate Finance United
States Securities and Exchange Commission 450 Fifth Street, N. W., Mail Stop 407
Washington, D.C. 20549
Re: Nexicon, Inc.
Form 10-KSB for Fiscal Year Ended December 31, 2004
Filed May 9, 2005
Forms 10-QSB for Fiscal Quarter Ended March 31, 2005
File No. 0-30244
Dear Mr. Spirgel:
We are in receipt of your comment letter dated June 14, 2005. This letter sets
forth the responses of the Company to the comment letter. Your comments are
reproduced below:
Form 10-KSB for Fiscal Year Ended December 31, 2004
Consolidated Statements of Operations, page F-3
COMMENT 1: Please refer to the line item non-cash stock
compensation expense. Please revise to either 1)
allocate the portion of non-cash stock compensation
to other operating expense line items including cost
of goods sold, general and administrative, and
research and development, or 2) parenthetically note
the amount of the equity-related charge being
excluded from each related operating expense line
item. Otherwise, explain to us why you believe that
no portion of this line item relates to any other
operating expenses.
RESPONSE: In response to the Commission's comment, the
requested revision has been made in Amendment No. 1
to Form 10-KSB and in Amendment No. 1 to Form 10-QSB.
<PAGE>
Mr. Larry Spirgel
June 27, 2005
Page 2
Note 1. Summary of Significant Accounting Policies, page F-7
Segment information, page F-9
COMMENT 2: We note your statement that you currently operate in one business
segment. However, we note that you have 2 divisions:
o Nexicon Billing Systems, a wholly owned subsidiary based in Lysaker,
Norway, which provides next-generation operational billing solutions
for telecom networks, enabling management, provisioning, invoicing,
and maintenance of end-users for fixed wireline telephony, mobile
telephony, internet, and energy utilities via a convergent
interface;
o Nexicon Security Solutions, a wholly owned subsidiary based in
McLean, Virginia, which offers network security and video
surveillance solutions for corporate, government, and military
purposes. Several of Nexicon Security Solutions' products are
currently deployed in U.S. Government pilot programs. Nexicon is
headquartered in Albuquerque, New Mexico, near the Los Alamos, White
Sands, and Sandia National Labs.
In this regard, tell us, citing specific accounting literature, why you
believe you currently operate in one business segment.
RESPONSE: The information requested related to business segments has been
added in Amendment No. 1 to the Form 10-KSB and in Amendment No. 1
to Form 10-QSB.
as requested by the Commission.
Note 13. Acquisition of Assets and Loss on Asset Impairment
OSSI, page F-17
COMMENT 3: We note that in exchange for all of the issued and outstanding
common shares of OSSI, you issued 50,000,000 shares of common stock
valued at $4,500,000. Given that as of September 31, 2003 you only
had 34,715,931 shares outstanding (Form 10-QSB for the fiscal
quarter ended September 30, 2003) tell us why you believe you are
the accounting acquirer. In your response address criteria a.
through e. of paragraph 17 of SFAS 141.
RESPONSE: In a business combination effected through an exchange of equity
interests, the entity that issues the equity interests is generally
the acquiring entity. In some business combinations (commonly
referred to as reverse acquisitions), however, the acquired entity
issues the equity interests. Commonly, the acquiring entity is the
larger entity. However, the facts and circumstances surrounding a
business combination sometimes indicate that a smaller entity
acquires a larger one. In some business combinations, the combined
<PAGE>
Mr. Larry Spirgel
June 27, 2005
Page 3
entity assumes the name of the acquired entity. Thus, in identifying
the acquiring entity in a combination effected through an exchange
of equity interests, all pertinent facts and circumstances shall be
considered, in particular:
a. The relative voting rights in the combined entity after the
combination-all else being equal, the acquiring entity is the combining
entity whose owners as a group retained or received the larger portion of
the voting rights in the combined entity. In determining which group of
owners retained or received the larger portion of the voting rights,
consideration shall be given to the existence of any unusual or special
voting arrangements and options, warrants, or convertible securities.
In this regard the shareholders of the Company retained 34,715,931
shares of common stock and a director/shareholder of the Company received
20,000,000 shares of the 50,000,000 shares issued to effect the
acquisition. The 54,715,931 shares retained by the Company's shareholders
represents 65% of the issued and outstanding shares immediately after the
acquisition.
b. The existence of a large minority voting interest in the combined
entity when no other owner or organized group of owners has a significant
voting interest-all else being equal, the acquiring entity is the
combining entity whose single owner or organized group of owners holds the
large minority voting interest in the combined entity.
c. The composition of the governing body of the combined entity-all else
being equal, the acquiring entity is the combining entity whose owners or
governing body has the ability to elect or appoint a voting majority of
the governing body of the combined.
The officers and directors of Nexicon, Inc. prior to the acquisition
were Francisco Urrea, Jr. - Director, Richard Urrea - Director and Chief
Executive Officer and Daniel Urrea - Chief Financial Officer.
d. The composition of the senior management of the combined entity-all
else being equal, the acquiring entity is the combining entity whose
senior management dominates that of the combined entity. Senior management
generally consists of the chairman of the board, chief executive officer,
chief operating officer, chief financial officer, and those divisional
heads reporting directly to them, or the executive committee if one
exists.
The officers and directors of Nexicon, Inc. after the acquisition were
Francisco Urrea, Jr. - Director, Richard Urrea - Director and Chief
Executive Officer, Daniel Urrea - Chief Financial Officer and Robert
Demson - Chief Operation Officer of OSSI.
e. The terms of the exchange of equity securities-all else being equal,
the acquiring entity is the combining entity that pays a premium over the
market value of the equity securities of the other combining entity or
entities.
<PAGE>
Mr. Larry Spirgel
June 27, 2005
Page 4
In addition, Orion was a development stage Company. The assets and
liabilities of the Company and the operations of the Company comprised a
majority of the assets (85% of the combined assets at September 30, 2003),
liabilities (62% of the combined liabilities at September 30, 2004) and
operations (74% of the loss before discontinued operations for the period
ended September 30, 2003) of the combined entity.
Pluto, page F-18
COMMENT 4: Tell us, citing accounting literature used, your basis for
recording the assets and liabilities acquired at historical
cost. Tell us why you believe the excess of purchase price
over the value of the assets acquired is purchased research
and development. Also, tell us and disclose in future filings.
o Specific nature and fair value of each significant
in-process research and development project acquired
o Completeness, complexity and uniqueness of the projects
at the acquisition date
o Nature, timing and estimated costs of the efforts
unnecessary to complete the projects, and the
anticipated completion dates
o Risks and uncertainties associated with completing
development on schedule, and consequences if it is not
completed timely
o Appraisal method used to value projects
o Significant appraisal assumptions, such as - period in
which material net cash inflows from significant
projects are expected to commence; material anticipated
changes from historical pricing, margins and expense
levels; and the risk adjusted discount rate applied to
the project's cash flows
o In periods after a significant write-off, discuss the
status of efforts to complete the projects, and the
impact of any delays on your expected investment return,
results of operations and financial condition.
RESPONSE: In response to the Commission's comment, please refer to our
response to the Commission's comment 5 below.
Central Solutions, page F-19
COMMENT 5: We note that the excess of the purchase price over the value
of the assets acquired has been recorded as purchased research
and development in the amount of $902,000 and charged to
operations during the period ended December 31, 2004. Tell us
and disclose in future filings:
<PAGE>
Mr. Larry Spirgel
June 27, 2005
Page 5
o Specific nature and fair value of each significant in
process research and development project acquired;
o Completeness, complexity and uniqueness of the projects
at the acquisition date;
o Nature, timing and estimated costs of the efforts
necessary to complete the projects, and the anticipated
completion dates;
o Risks and uncertainties associated with completing
development on schedule, and consequences if it is not
completed timely;
o Appraisal method used to value projects;
o Significant appraisal assumptions, such as - period in
which material net cash inflows from significant
projects are expected to continence material anticipated
changes from historical pricing, margins and expense
levels; and the risk adjusted discount rate applied to
the project's cash flows;
o In periods after a significant write-off, discuss the
status of efforts to complete the projects, and the
impact of any delays on your expected investment return,
results of operations and financial condition.
RESPONSE: The assets and liabilities were recorded at fair values which
was equal to historical cost. Our disclosures in Amendment No.
1 to Form 10-KSB have been amended to indicate this.
The excess of the purchase price over the fair values has been
recorded as purchased research.
SFAS 141 paragraph 22 states - The fair value of securities traded
in the market is generally more clearly evident than the fair value
of an acquired entity. Thus, the quoted market price of an equity
security issued to effect a business combination generally should be
used to estimate the fair value of an acquired entity after
recognizing possible effects of price fluctuations, quantities
traded, issue costs, and the like. The Company used the trading
value of the common shares issued to determine the purchase price.
Pursuant to staff guidance in the past this is the preferred
valuation with a nominal discount for marketability (which the
Company has elected not to take).
SFAS 141 paragraph 42 further states - This Statement does not
change the requirement in paragraph 5 of FASB Interpretation No. 4,
Applicability of FASB Statement No. 2 to Business Combinations
Accounted for by the Purchase Method, that the amounts assigned to
tangible and intangible assets to be used in a particular research
and development project that have no alternative future use shall be
charged to expense at the acquisition date. This is the accounting
treatment that the Company utilized, which is consistent with
<PAGE>
Mr. Larry Spirgel
June 27, 2005
Page 6
guidance provided by the staff for the allocation of the excess of
the purchase price over the fair value of the assets acquired which
have no determinable future use (see the discussion below).
FASB Interpretation No. 4
Broad guidelines about the activities to be classified as research
and development and the elements of costs to be identified with
those activities are set forth in paragraphs 8-11 of Statement No.
2. Paragraph 12 of that Statement provides that research and
development costs shall be charged to expense when incurred.
However, some costs associated with research and development
activities shall be capitalized if the item has alternative future
uses in research and development or otherwise. The cost of materials
consumed, the depreciation of equipment and facilities used, and the
amortization of intangibles used in research and development
activities are research and development costs.
Statement No. 2 amends APB Opinion No. 17, "Intangible Assets," to
exclude from the scope of that Opinion those research and
development costs encompassed by the Statement but does not amend
APB Opinion No. 16, "Business Combinations." Paragraph 34 of the
Statement indicates that paragraph 11(c) is not intended to alter
the conclusions in paragraphs 87-88 of APB Opinion No. 16 regarding
allocation of cost to assets acquired in a business combination
accounted for by the purchase method.
The intent of paragraph 3